COMT and Parkinson disease: While numerous studies have explored associations between COMT variants and PD susceptibility [4], particularly the Val158Met (rs4680), and their impact on levodopa-induced dyskinesia (LID) [5,6], cognitive decline [7–9], and motor fluctuations [10], findings remain inconsistent, leaving the role of COMT and variants in close proximity unresolved.